Bimatoprost 0.01% or 0.03% in patients with glaucoma or ocular hypertension previously treated with latanoprost: two randomized 12-week trials

Jonathan S Myers,1 Steven Vold,2 Fiaz Zaman,3 Julia M Williams,4 David A Hollander41Wills Eye Hospital, Philadelphia, PA, USA; 2Vold Vision, PLLC, Bentonville, AR, USA; 3Houston Eye Associates, Houston, TX, USA; 4Allergan, Inc., Irvine, CA, USABackground: The purpose of this study was to evaluate t...

Full description

Saved in:
Bibliographic Details
Main Authors: Myers JS, Vold S, Zaman F, Williams JM, Hollander DA
Format: article
Language:EN
Published: Dove Medical Press 2014
Subjects:
Online Access:https://doaj.org/article/750d12ae7bef44c3800eea8aeeb0550e
Tags: Add Tag
No Tags, Be the first to tag this record!